14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MCHP vs AMBQ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Microchip Technology Inc (MCHP) is the stronger overall head-to-head candidate over Ambiq Micro, Inc. (AMBQ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MCHP carries a Unified Composite Score of 59.9/100 (HOLD) at $59.57 (23.2x Forward P/E, 21.6% operating margin), whereas AMBQ carries 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin).
Growth vs. Quality Trade-Off: MCHP earns the overall head-to-head edge with a stronger Unified Composite Score (59.9/100 HOLD vs. AMBQ 46.9/100 HOLD) and 2.45β · 74% Vol risk profile, whereas AMBQ leads top-line expansion (+110.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: MCHP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.0); meanwhile AMBQ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Semiconductors value chain with $1.2B market capitalization and -36.0% operating margin.
OpEx & R&D Reinvestment80.8% of Rev ($95M)
90D Engineering Disclosures0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing CompanyARM HoldingsSynopsysCadence Design Systems
Investor FAQ MCHP vs AMBQ Key Questions & Quantitative Answers
As of Nov 16, 2026, Microchip Technology Inc (MCHP) is the stronger overall head-to-head candidate over Ambiq Micro, Inc. (AMBQ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MCHP carries a Unified Composite Score of 59.9/100 (HOLD) at $59.57 (23.2x Forward P/E, 21.6% operating margin), whereas AMBQ carries 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin). Growth vs. Quality Trade-Off: MCHP earns the overall head-to-head edge with a stronger Unified Composite Score (59.9/100 HOLD vs. AMBQ 46.9/100 HOLD) and 2.45β · 74% Vol risk profile, whereas AMBQ leads top-line expansion (+110.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: MCHP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.0); meanwhile AMBQ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AMBQ leads the Growth & Scale pillar: MCHP posts +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin), compared with AMBQ at +110.0% YoY revenue growth and +0.0% YoY earnings growth on $118M TTM revenue (44.8% gross margin, -36.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), MCHP cumulative revenue shifted -12.0% while AMBQ shifted -12.5%. In operating R&D and SG&A reinvestment, MCHP deploys 41.1% of Rev ($2.30B) (0 90-day corporate R&D disclosures) versus 80.8% of Rev ($95M) (0 disclosures) for AMBQ.
MCHP screens cheaper on headline valuation multiples. MCHP trades at 23.2x Forward P/E, 46.7x Trailing P/E, 0.19x PEG, and 6.9x EV/Revenue (26.0% FCF margin), whereas AMBQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 7.3x EV/Revenue (-33.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MCHP (12.6% ROE) versus AMBQ (-12.2% ROE) capital efficiency.
In options market volatility and institutional positioning, MCHP carries 831.6% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.16x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.45β · 74% Vol realized risk). By comparison, AMBQ carries 96.5% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 2.14x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.71β · 125% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.